Drug Interactions between Carafate and lisinopril
This report displays the potential drug interactions for the following 2 drugs:
- Carafate (sucralfate)
- lisinopril
Interactions between your drugs
No interactions were found between Carafate and lisinopril. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Carafate
A total of 149 drugs are known to interact with Carafate.
- Carafate is in the drug class miscellaneous GI agents.
- Carafate is used to treat the following conditions:
lisinopril
A total of 364 drugs are known to interact with lisinopril.
- Lisinopril is in the drug class Angiotensin Converting Enzyme Inhibitors.
- Lisinopril is used to treat the following conditions:
Drug and food interactions
sucralfate food
Applies to: Carafate (sucralfate)
When sucralfate is given with enteral (tube) feedings, the feeding tube may become clogged and/or sucralfate may not work as well. You could interrupt the feeding for 1 hour before and after the sucralfate dose. However, this still may not entirely avoid the interaction and may not always be feasible. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
lisinopril food
Applies to: lisinopril
It is recommended that if you are taking lisinopril you should be advised to avoid moderately high or high potassium dietary intake. This can cause high levels of potassium in your blood. Do not use salt substitutes or potassium supplements while taking lisinopril, unless your doctor has told you to.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See Also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.